Back to search

National Technical University of Athens (NTUA)

Σχεδιασμός και σύνθεση νέων κουμαρινικών παραγώγων και νανοτεχνολογική προσέγγιση για την πιθανή αξιοποίησή τους σε φαρμακευτικές εφαρμογές

Abstract

dc:description

The aim of the present doctoral research is the design and synthesis of novel coumarin analogues with significant biological activity. Seven series of structurally modified coumarin derivatives (Series A-Series G) were synthesized, containing 100 molecules, the majority of which is presented in the literature for the first time. The novel analogues were characterized using Nuclear Magnetic Resonance spectroscopy (1H and 13C NMR) as well as High Resolution Mass Spectrometry (HR-MS).Series Α and Β: The synthesis of the novel 3-aryl-coumarin derivatives of Series A and B was accomplished in two stages: the acetyloxy coumarin analogues were synthesized first using a modified Perkin-Oglialoro reaction (3a-3o & 9a-9j), while the removal of the acetyl group led to the synthesis of the corresponding hydroxy coumarin analogues (4a-4k & 10a-10j). The novel 3-aryl-coumarin analogues were examined for their antioxidant activity using the DPPH, ABTS·+ and ·ΟΗ radical scavenging assays, as well as by testing their ability to inhibit lipid peroxidation induced by AAPH. Moreover, their soybean lipoxygenase (LOX) inhibitory activity was evaluated as an indication of their anti-inflammatory activity, along with their cytotoxic activity against various cancer cell lines. Molecular docking studies of compounds 3-(4-acetyloxyphenyl)-6,8-dibromo-4-methyl-coumarin (3k) and 4-methyl-5-hydroxy-3-(3-fluorophenyl)-coumarin (4e) which were the strongest LOX inhibitors (IC50 8.7 and 4.1 μM, respectively) were performed, indicating allosteric interactions with the enzyme. In addition, the calf thymus DNA (ctDNA) binding ability of selected coumarin derivatives of Series B was assessed, while the human oral absorption and plasma protein binding properties of compounds of Series A were estimated using biomimetic chromatography.Series C and D: Five novel coumarin carboxamide derivatives (17a-17e, Series C) and three novel aminoethoxy-coumarin derivatives (22a-22c, Series D) were synthesized and evaluated for their acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) inhibitory activity as an indication of their neuroprotective ability. The compounds presented IC50 values of 34.9-94.2 μΜ and 10-100 μΜ, respectively. Moreover, molecular docking studies of the coumarin derivatives that exhibited significant anti-AChE activity were performed, indicating interactions with key amino acid residues of the enzyme.Series Ε: Four novel coumarin-chalcone hybrids (26a-26d) were synthesized and evaluated for their lipid peroxidation (16-94%) and soybean LOX inhibitory ability (IC50 32.5-100 μΜ), as well as cytotoxicity against prostate cancer cell line LNCaP (IC50 59-130 μΜ). Their photophysical properties were examined, along with their ability to generate reactive oxygen species in vitro, while they also exhibited significant phototoxicity against squamous carcinoma A431 cell line, with compound 26b reducing the cell viability to 26%.Series F: This series of compounds is composed of ten novel biscoumarins (32a-32j), three fused benzopyranocoumarins (33a-33c) and two novel quinolinones (34a, 34b), synthesized using the natural deep eutectic solvent L-proline/lactic acid = 1:2. It is noteworthy that the synthesis of the quinolinone analogues using this method is reported for the first time. Two-dimensional Nuclear Magnetic Resonance spectroscopy (2D NMR) was used for the complete characterization and structure identification of fused benzopyranocoumarin 33b and quinolinone 34a. Moreover, the antioxidant activity of the compounds was examined using the DPPH radical scavenging and lipid peroxidation (LP) inhibition assays. All the biscoumarin analogues presented significant antioxidant activity, while compound 32c is the most potent antioxidant agent.Series G: The Suzuki-Miyaura coupling was used for the synthesis of ten novel 3,6-disubstituted coumarin analogues of Series G (35a-35j) using the natural deep eutectic solvent choline chloride/glycerol = 1:2, while it was observed that palladium nanoparticles were formed during the reaction, which play an important role for its success. The novel coumarin derivatives were examined for their cytotoxic activity against A431 cell line, while the majority of the compounds presented significant cytotoxicity (40-60% at the concentration of 100 μΜ).Moreover, the encapsulation of selected coumarin analogues in next generation lipid nanosystems was achieved. In this context, the natural coumarin daphnetin (7,8-dihydroxy-coumarin) and its synthetic analogue, 7,8-dihydroxy-3-(4-hydroxyphenyl)-4-methyl-coumarin, were encapsulated in Solid Lipid Nanoparticles (SLNs). The SLNs were characterized using several methods, while their release profile was examined under different conditions. The antioxidant activity of the coumarin analogues and their SLNs was also assessed and it was observed that the SLNs of the coumarins exhibited higher antioxidant activity than the free compounds. Intracellular localization studies indicated the enhanced cellular uptake of the coumarin analogues when loaded in the SLNs. In addition, the photosensitizing properties of the coumarins and their SLNs were studied, indicating that 7,8-dihydroxy-3-(4-hydroxyphenyl)-4-methyl-coumarin is a very promising photosensitizer both in free and encapsulated form, reducing the cell viability to 11% (after irradiation with 12 mW/cm2 for 3 min).Finally, 7,8-dihydroxy-4-phenyl-4-methyl-coumarin was encapsulated in three different latest generation lipid nanosystems: Solid Lipid Nanoparticles (SLNs), Nanostructured Lipid Carriers (NLCs) and niosomes. The lipid nanosystems were characterized using FT-IR spectroscopy and thermogravimetric analysis (TGA), while their release profile and their DPPH radical scavenging activity were also assessed. The NLCs formulation presented the highest encapsulation efficiency (84%), while it also better preserved the antioxidant activity of the compound.

Degree

thesis:*
Grantor dc:publisher
National Technical University of Athens (NTUA)
Year dc:date
2023

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Katopodi, Annita
  • Κατωπόδη, Αννίτα

Subjects

dc:subject × 36

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/54645

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Katopodi, Annita; Κατωπόδη, Αννίτα. Σχεδιασμός και σύνθεση νέων κουμαρινικών παραγώγων και νανοτεχνολογική προσέγγιση για την πιθανή αξιοποίησή τους σε φαρμακευτικές εφαρμογές. National Technical University of Athens (NTUA), 2023. http://hdl.handle.net/10442/hedi/54645